Related Experiment Video
Updated: Jun 23, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Insights
This systematic review evaluates treatments for acute gout and gout prevention. It found 21 studies on interventions like NSAIDs, colchicine, and lifestyle changes, assessing their effectiveness and safety.
Area of Science:
- Rheumatology
- Clinical Pharmacology
Background:
- Gout prevalence: 5% of men, 1% of women.
- High recurrence rate: up to 80% within 3 years.
Purpose of the Study:
- Evaluate treatments for acute gout attacks.
- Assess interventions for gout prevention in patients with prior episodes.
Main Methods:
- Systematic review of 21 studies (reviews, RCTs, observational).
- Searched Medline, Embase, Cochrane Library up to June 2008.
- Included FDA and MHRA harms alerts.
- GRADE evaluation of evidence quality.
Main Results:
- Synthesized evidence on various gout interventions.
- Assessed effectiveness and safety of treatments.
Conclusions:
- Information presented on colchicine, corticosteroids, ACTH, NSAIDs, sulfinpyrazone, xanthine oxidase inhibitors.
- Includes lifestyle advice: weight loss, reduced alcohol, and purine intake modification.
Introduction:
Gout affects about 5% of men and 1% of women, with up to 80% of people experiencing a recurrent attack within 3 years.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of treatments for acute gout? What are the effects of treatments to prevent gout in people with prior acute episodes? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2008 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
We found 21 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of the following interventions: colchicine, corticosteroids, corticotrophin (ACTH), non-steroidal anti-inflammatory drugs (NSAIDs), sulfinpyrazone, xanthine oxidase inhibitors, advice to lose weight, advice to reduce alcohol intake, advice to reduce dietary intake of purines.
Related Concept Videos
Cholecystitis
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Gallbladder
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins the common...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...